Drug Manufacturers General industry stocks
The Drug Manufacturers General industry has 21 US-listed companies on stockrow and is part of the Healthcare sector, with a combined market value of $4.18T. Eli Lilly and Company (LLY) is the largest at $1.11T, followed by Johnson & Johnson and AbbVie Inc.. The median Drug Manufacturers General stock trades at 24.7× trailing earnings, above the market median of 17.9×, with a median net margin of 8.27% (market: 0.55%). Median revenue growth over the last twelve months is 6.79%. 15 of the 21 pay a dividend; the median yield among payers is 3.57%.
Drug Manufacturers General medians
| Metric | Industry | Market |
|---|---|---|
| P/E | 24.7× | 17.9× |
| P/S | 3.3× | 2.0× |
| P/B | 5.0× | 1.8× |
| Price to free cash flow | 17.7× | 14.0× |
| EV/EBITDA | 13.9× | 11.0× |
| EV/Sales | 4.0× | 2.2× |
| Earnings yield | 2.92% | 1.18% |
| Free cash flow yield | 4.42% | 0.48% |
| Gross margin | 72.8% | 46.3% |
| Operating margin | 18.9% | 0.00% |
| Net margin | 8.27% | 0.55% |
| Free cash flow margin | 17.3% | 0.00% |
| Return on equity | 6.97% | 1.76% |
| Return on assets | 2.76% | 0.00% |
| Return on invested capital | 6.30% | 0.00% |
| Revenue growth (TTM) | 6.79% | 7.41% |
| Revenue growth, 5-year CAGR | 3.98% | 8.85% |
| Net income growth, 5-year CAGR | 0.42% | 0.00% |
| Debt to equity | 0.6× | 0.2× |
| Current ratio | 1.3× | 1.6× |
| Net debt to EBITDA | 1.2× | 0.6× |
| Dividend yield | 3.57% | 2.75% |
| Payout ratio | 0.5× | 0.0× |
| Market cap | $125.9B | $612.7M |
Today’s biggest moves
All 21 companies
Open in screener| MDCX | Medicus Pharma Ltd | 10.03m | 0.15 | (6.25%) | 0.00 | 0.00% | — | — |
|---|---|---|---|---|---|---|---|---|
| SCLX | Scilex Holding Company | 34.75m | 4.89 | (1.01%) | 0.00 | (1,418.45%) | (28.55%) | — |
| MIRA | MIRA Pharmaceuticals, Inc. | 35.28m | 0.90 | 7.14% | 0.00 | 0.00% | — | — |
| NSRX | Nasus Pharma Ltd. | 40.75m | 3.48 | 0.00% | — | — | — | — |
| AMRN | Amarin Corporation PLC | 283.64m | 13.20 | (1.71%) | 0.00 | (14.56%) | (15.10%) | — |
| GRFS | Grifols, S.A. | 1.86b | 7.35 | 2.08% | 8.14 | 5.54% | 16.03% | 0.15% |
| OGN | Organon & Co. | 3.60b | 13.73 | 0.07% | 17.38 | 3.41% | (2.45%) | 6.88% |
| BIIB | Biogen Inc. | 33.54b | 227.60 | 0.55% | 40.07 | 8.32% | 0.31% | — |
| SNY | Sanofi | 97.44b | 41.11 | 0.42% | 21.52 | 8.22% | 21.30% | 4.40% |
| GSK | GSK PLC Sponsored ADR | 100.08b | 49.24 | (0.83%) | 15.34 | 14.58% | 8.72% | 3.66% |
| BMY | Bristol Myers Squibb Company | 125.91b | 62.86 | 2.21% | 13.85 | 18.87% | 3.11% | 5.04% |
| NVO | Novo Nordisk A/S | 129.28b | 38.80 | 0.47% | 9.49 | 35.47% | 13.15% | 1.36% |
| PFE | Pfizer Inc. | 161.70b | 28.67 | 0.88% | 37.71 | 6.80% | (0.21%) | 6.18% |
| GILD | Gilead Sciences, Inc. | 183.22b | 150.93 | 0.83% | 0.00 | (10.64%) | 5.52% | 4.27% |
| AMGN | Amgen Inc. | 219.05b | 414.61 | 2.11% | 25.56 | 22.95% | 9.10% | 3.16% |
| AZN | AstraZeneca PLC | 257.79b | 166.58 | 1.23% | 24.72 | 17.02% | 8.61% | 2.49% |
| NVS | Novartis AG | 264.33b | 145.46 | 1.93% | 21.84 | 22.50% | 2.73% | 3.69% |
| MRK | Merck & Co., Inc. | 365.36b | 148.78 | 0.54% | 119.02 | 4.77% | 4.64% | 2.58% |
| ABBV | AbbVie Inc. | 467.37b | 264.34 | (0.29%) | 74.67 | 9.74% | 10.39% | 3.57% |
| JNJ | Johnson & Johnson | 652.82b | 271.22 | 0.20% | 31.43 | 21.48% | 8.06% | 3.07% |
| LLY | Eli Lilly and Company | 1.11t | 1,183.46 | 0.13% | 39.71 | 33.53% | 49.58% | 0.72% |